Get started Log in

IPD — ImpediMed News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
AU$14.64m
Enterprise Value
AU$15.95m
Revenue
AU$14.61m

Australia Stock Exchange release from IMPEDIMED : ImpediMed Announces End Stage Renal Disease Trial Agreement

10/02/2022 21:49

Australia Stock Exchange release from IMPEDIMED  IPD.AX : ImpediMed Announces End Stage Renal Disease Trial Agreement

Recent news on ImpediMed

Australia's ImpediMed falls to record low on discounted placement
04/05/2026 03:55
Brief: Impedimed Receives Commitments To Raise A$13.2 Million
04/05/2026 02:01
Brief: Impedimed Logs Qtrly Revenue A$3.5 Mln
30/04/2026 02:42
Brief: Impedimed Requests Trading Halt
30/04/2026 02:31
Brief: Impedimed Appoints Erik Anderson As Managing Director And CEO
07/04/2026 03:29